Legal & General Group PLC Molecular Templates, Inc. Transaction History

Legal & General Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$0.81 - $3.43 $3,181 - $13,473	-3,928 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $25,325 - $51,628	-7,515 Reduced 65.67%	3,928 $15,000
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $38,356 - $52,158	6,636 Added 138.05%	11,443 $77,000
Q2 2021 Aug 12, 2021	BUY	$7.82 - $12.44 $6,748 - $10,735	863 Added 21.88%	4,807 $38,000
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $1,642 - $2,472	-176 Reduced 4.27%	3,944 $50,000
Q3 2020 Nov 13, 2020	SELL	$9.99 - $14.41 $7,552 - $10,893	-756 Reduced 15.5%	4,120 $45,000
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $23,565 - $33,831	1,919 Added 64.9%	4,876 $67,000
Q1 2020 May 14, 2020	SELL	$11.31 - $18.26 $3,302 - $5,331	-292 Reduced 8.99%	2,957 $39,000
Q4 2019 Feb 13, 2020	BUY	$6.44 - $14.21 $2,685 - $5,925	417 Added 14.72%	3,249 $45,000
Q2 2019 Aug 14, 2019	BUY	$5.83 - $8.42 $6,459 - $9,329	1,108 Added 64.27%	2,832 $22,000
Q2 2018 Aug 10, 2018	BUY	$5.19 - $9.71 $8,947 - $16,740	1,724 New	1,724 $9,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $7.33M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.